Universitätsklinikum Dresden

Dresden, Saxony 1307

1 studies enrolling now · 5 studies all time

What they study most

Chronic Inducible Urticaria, Chronic Spontaneous Urticaria, Colorectal Cancer, Leukemia Relapse, Leukemia and Lymphoma, Lymphoma Diffuse Large B-cell, Lymphoma Receiving CAR-T Therapy, Metastatic Bladder Cancer, Urinary Tract Neoplasms, Urologic Neoplasms

Studies at this site

• Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies — Recruiting now
• A Study of CDX-0159 in Patients With Chronic Inducible Urticaria — Completed
• A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria — Completed
• Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma — Stopped early
• A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer — Completed